| Literature DB >> 33472364 |
Drew Capone1,2, Aaron Bivins3, Jackie Knee4, Oliver Cumming4, Rassul Nalá5, Joe Brown1,2.
Abstract
Rigorous studies of water, sanitation, and hygiene interventions in low- and middle-income countries (LMICs) suggest that children are exposed to enteric pathogens via multiple interacting pathways, including soil ingestion. In 30 compounds (household clusters) in low-income urban Maputo, Mozambique, we cultured Escherichia coli and quantified gene targets from soils (E. coli: ybbW, Shigella/enteroinvasive E. coli (EIEC): ipaH, Giardia duodenalis: β-giardin) using droplet digital PCR at three compound locations (latrine entrance, solid waste area, dishwashing area). We found that 88% of samples were positive for culturable E. coli (mean = 3.2 log10 CFUs per gram of dry soil), 100% for molecular E. coli (mean = 5.9 log10 gene copies per gram of dry soil), 44% for ipaH (mean = 2.5 log10), and 41% for β-giardin (mean = 2.1 log10). Performing stochastic quantitative microbial risk assessment using soil ingestion parameters from an LMIC setting for children 12-23 months old, we estimated that the median annual infection risk by G. duodenalis was 7100-fold (71% annual infection risk) and by Shigella/EIEC was 4000-fold (40% annual infection risk) greater than the EPA's standard for drinking water. Compounds in Maputo, and similar settings, require contact and source control strategies to reduce the ingestion of contaminated soil and achieve acceptable levels of risk.Entities:
Year: 2021 PMID: 33472364 PMCID: PMC7860170 DOI: 10.1021/acs.est.0c06972
Source DB: PubMed Journal: Environ Sci Technol ISSN: 0013-936X Impact factor: 9.028
Input Parameters for QMRA Model
| model variable | stochastic parameters used | references |
|---|---|---|
| nondetect
values of | U(0, 95% LOD) | Stokdyk et al. 2016[ |
| Canales et al. 2018[ | ||
| nondetect values of CFUs | U(0, LOD) | Canales
et al. 2018[ |
| gene copies | LN distribution with the following LN parameter distributions: | MLE, this study |
| mean = LN (1.5, 0.019) | ||
| sd = LN (0.45, 0.076) | ||
| gene
copies | LN distribution with the following LN parameter distributions: | MLE, this study |
| mean = LN (1.7, 0.016) | ||
| sd = LN (0.41, 0.078) | ||
| soil ingested (grams/day) (EPA 2017) | <6 months: LN(−4.2, 0.78) (mean = 40 mg/day, sd = 31 mg/day) | EPA Exposure Factors Handbook
Chapter 5 (2017
update)[ |
| 6–11 months: LN(−4.0, 0.95) (mean = 70 mg/day, sd = 66 mg/day) | ||
| 12–23 months: LN(−3.4, 0.68) (mean = 90 mg/day, sd = 56 mg/day) | ||
| 24–71 months: LN(−4.0, 0.95) (mean = 60 mg/day, sd = 71 mg/day) | ||
| soil ingested (grams/day) (Kwong et al. 2019) | 3–5 months: LN(−1.8, 0.69) (geometric mean = 162 mg/day, geo sd = 2) | Kwong et al. 2019[ |
| 6–11 months: LN(−1.5, 0.69) (geometric mean = 224 mg/day, geo sd = 2) | ||
| 12–23 months: LN(−1.5, 0.69) (geometric mean = 234 mg/day, geo sd = 2) | ||
| 24–35 months: LN(−1.8, 0.69) (geometric mean = 168 mg/day, geo sd = 2) | ||
| 36–47 months: LN(−1.7, 0.69) (geometric mean = 178 mg/day, geo sd = 2) | ||
| soil ingested (grams/day) for Geophagy (Geissler et al. 1997) | 12–71 months: Tri(8, 28, 108) (minimum = 8 g/day, mode = 28 g/day, maximum = 108 g/day) | Geissler et al. 1997[ |
| culturable | N (3.2, 1.1) | this study |
| N (5.9, 0.36) | this study | |
| ratio of viable | LN(−6.2, 2.4) | MLE, this study |
| LN distribution from ratios of CFUs | ||
| ratio of viable | LN(−6.2, 2.4) | MLE, this study |
| LN distribution from ratios of CFUs | ||
| 16 | Bernander et al. 2001[ | |
| i | U(5,14) | Lin et al.
2010[ |
| 1 | Walker et al. 2017[ | |
| LN (0.0208, 0.0064) | Rose et al. 1991[ | |
| log α N (−0.5768, 0.0961) | Dupont | |
| log N50 N (3.170, 0.1397) | Crockett et al. 1996[ | |
Note: LN = log–normal (mean, sd); N = normal (mean, sd); U = uniform (min, max); and Tri = triangle (min, mode, max). Values correspond to the inputs used for the rlnorm, rnorm, rtri functions in R.
Figure 1Results from molecular- and culture-based assays. All nondetects (NDs) were imputed to a random value from zero to the 95% LOD for molecular assays and from zero to the LOD for the culture-based assay.
Estimated Annual Infection Risks
| Model output using soil ingestion estimates from the U.S. EPA Exposure Factors Handbook | |||||
|---|---|---|---|---|---|
| estimated | |||||
| percentile | 10th (%) | 50th (%) | 90th (%) | MapSan | |
| age | <6 months | 9.6 | 15 | 29 | 13 |
| 6–11 months | 16 | 26 | 54 | 22 | |
| 12–23 months | 20 | 31 | 48 | 59 | |
| 24–71 months | 13 | 21 | 38 | 73 | |
| estimated | |||||
| age | <6 months | 4.4 | 7.3 | 14 | 5.0 |
| 6–11 months | 7.2 | 12 | 20 | 21 | |
| 12–23 months | 9.4 | 15 | 25 | 36 | |
| 24–71 months | 5.9 | 10 | 19 | 68 | |
Note: MapSan point prevalence data represents a total of 922 children enrolled in the MapSan trial. Annual risk is for a single infection.
Figure 2(A) Kernel density plot of the estimated annual risk of a single infection using ingestion parameters from Kwong et al. 2019 for children 12–23 months old. (B) Kernel density plot of the estimated annual risk of infection using ingestion parameters from Kwong et al. 2019 for children 12–23 months old.
Sensitivity Analysis
| estimated
annual risk (percentile) | ||||||
|---|---|---|---|---|---|---|
| 10th (%) | 50th (%) | 90th (%) | ||||
| soil ingestion | 10 | mg/day | 2.7 | 4.4 | 8.1 | |
| 100 | 24 | 36 | 57 | |||
| 1000 | 93 | 99 | >99 | |||
| gene copy density | 10 | gene copies/gram soil | 2.6 | 3.7 | 5.3 | |
| 100 | 23 | 32 | 43 | |||
| 1000 | 92 | 98 | >99 | |||
| viability | 0.01% | % viable cysts | 0.51 | 0.65 | 0.92 | |
| 0.10% | 5.0 | 6.4 | 8.8 | |||
| 1% | 40 | 48 | 60 | |||
| 10% | >99 | >99 | >99 | |||
| dose–response
parameter | 0.00995 | unitless | 31 | 46 | 78 | |
| 0.0199 | 53 | 71 | 95 | |||
| 0.0398 | 78 | 92 | >99 | |||
| soil ingestion | 10 | mg/day | 1.2 | 1.9 | 3.3 | |
| 100 | 11 | 17 | 27 | |||
| 1000 | 65 | 78 | 88 | |||
| gene copy density | 10 | gene copies/gram soil | 0.60 | 0.89 | 1.3 | |
| 100 | 5.8 | 8.4 | 12 | |||
| 1000 | 43 | 55 | 66 | |||
| viability | 0.01% | % viable CFUs | 0.22 | 0.29 | 0.43 | |
| 0.10% | 2.2 | 2.8 | 4.1 | |||
| 1% | 20 | 24 | 32 | |||
| 10% | 87 | 91 | 95 | |||
| dose–response parameter | 740 | CFUs | 42 | 56 | 72 | |
| 1480 | 25 | 35 | 50 | |||
| 2960 | 13 | 20 | 31 | |||
Results from sensitivity analysis that held individual parameters constant as part of the stochastic QMRA model.